N-[(2R,5R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N-[(2R,5R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
• 化学式: C₈H₁₅NO₆
• 分子量: 221.21
• InChiKey: OVRNDRQMDRJTHS-GBZOPPSHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  119
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• [EN] CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS ANTISENS CONJUGUÉS ET LEUR UTILISATION
  申请人：ISIS PHARMACEUTICALS INC

  公开号：WO2014179620A1

  公开（公告）日：2014-11-06

  Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.

  本文提供了具有共轭基团的寡聚化合物。在某些实施例中，这些寡聚化合物与N-乙酰半乳糖结合。
• [EN] TARGETED THERAPEUTIC NUCLEOSIDES AND THEIR USE<br/>[FR] NUCLÉOSIDES THÉRAPEUTIQUES CIBLÉES ET LEUR UTILISATION
  申请人：ISIS PHARMACEUTICALS INC

  公开号：WO2015042447A1

  公开（公告）日：2015-03-26

  Provided herein are compounds comprising one or more therapeutic nucleosides and one or more targeting groups. In certain embodiments, the compounds further comprise one or more oligonucleotides. In certain embodiments, a targeting group comprises one or more N-Acetylgalactosamine.

  本文提供的化合物包括一个或多个治疗性核苷和一个或多个靶向基团。在某些实施例中，这些化合物进一步包括一个或多个寡核苷酸。在某些实施例中，一个靶向基团包括一个或多个N-乙酰半乳糖胺。
• NOVEL AMPHIPHILIC DERIVATIVES OF ALPHA-C-PHENYL-N-TERT-BUTYLNITRONE
  申请人：Durand Grégory

  公开号：US20090306001A1

  公开（公告）日：2009-12-10

  Compounds derived from α-C-phenyl-N-tert-butylnitrone, a process for the preparation thereof and use thereof for the preparation of medicaments for use in preventing or treating oxidative stress-related diseases.

  从α-C-苯基-N-叔丁基亚甲基腈衍生的化合物，其制备方法以及用于制备用于预防或治疗与氧化应激相关疾病的药物的用途。
• Solid-Phase Oligosaccharide Tagging: a Technique for Manipulation of Immobilized Carbohydrates
  申请人：Lohse Anders

  公开号：US20080227092A1

  公开（公告）日：2008-09-18

  The invention relates to methods of manipulating immobilised carbohydrates by derivatisation. Depending on the nature of the derivatisation, the carbohydrate may thereby be more easily detected and/or identified or handled. In particular, the invention relates to methods of preparing a reactive sugar comprising the steps of: i) providing a sample comprising a reducing sugar; ii) providing a solid support covalently attached to a linker comprising a capture group comprising an —NH2 group, wherein said linker optionally is attached to said solid support via a spacer; iii) reacting said reducing sugar with said —NH2 group, thereby obtaining an immobilised sugar; iv) reacting free —NH2 groups with a capping agent, wherein the capping agent comprises a reactive group capable of reacting with an —NH2 group; and v) reducing C═N bonds with a reducing agent, thereby obtaining an reactive sugar of the structure SugarCH n —NH— linked to a solid support via a linker and optionally a spacer, wherein n is 1 or 2.

  本发明涉及通过衍生化来操纵固定化碳水化合物的方法。根据衍生化的性质，碳水化合物可以更容易地被检测和/或识别或处理。特别地，本发明涉及制备反应性糖的方法，包括以下步骤：i）提供包含还原糖的样品；ii）提供共价连接到捕获基团（包括—NH2基团）的连接剂的固体支持，其中所述连接剂可以通过间隔物连接到所述固体支持；iii）将还原糖与所述—NH2基团反应，从而获得固定化糖；iv）用盖帽剂反应自由—NH2基团，所述盖帽剂包括能够与—NH2基团反应的反应性基团；v）用还原剂还原C═N键，从而获得结构为SugarCHn—NH—的反应性糖，其通过连接剂和可选的间隔物与固体支持连接，其中n为1或2。
• RADIOLABELED ANNEXINS
  申请人：Kasina Sudhakar

  公开号：US20110269943A1

  公开（公告）日：2011-11-03

  Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.

  本文描述了用于成像血管血栓的放射性标记的附加素和修饰的附加素偶联物。还提供了制备和使用这种放射性标记的附加素偶联物的方法。